105 related articles for article (PubMed ID: 11675936)
21. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
Lai SL; Hwang J; Perng RP; Whang-Peng J
Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
[TBL] [Abstract][Full Text] [Related]
22. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
Cole SP; Downes HF; Mirski SE; Clements DJ
Mol Pharmacol; 1990 Feb; 37(2):192-7. PubMed ID: 1968221
[TBL] [Abstract][Full Text] [Related]
23. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
[TBL] [Abstract][Full Text] [Related]
24. Direct evidence for glutathione as mediator of apoptosis in neuronal cells.
Nicole A; Santiard-Baron D; Ceballos-Picot I
Biomed Pharmacother; 1998; 52(9):349-55. PubMed ID: 9856280
[TBL] [Abstract][Full Text] [Related]
25. Glutathione depletion induces giant DNA and high-molecular-weight DNA fragmentation associated with apoptosis through lipid peroxidation and protein kinase C activation in C6 glioma cells.
Higuchi Y; Matsukawa S
Arch Biochem Biophys; 1999 Mar; 363(1):33-42. PubMed ID: 10049497
[TBL] [Abstract][Full Text] [Related]
26. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
Ramos AM; Aller P
Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
[TBL] [Abstract][Full Text] [Related]
27. The selection between apoptosis and necrosis is differentially regulated in hydrogen peroxide-treated and glutathione-depleted human promonocytic cells.
Troyano A; Sancho P; Fernández C; de Blas E; Bernardi P; Aller P
Cell Death Differ; 2003 Aug; 10(8):889-98. PubMed ID: 12867996
[TBL] [Abstract][Full Text] [Related]
28. Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line.
Pendyala L; Perez R; Weinstein A; Zdanowicz J; Creaven PJ
Cancer Chemother Pharmacol; 1997; 40(1):38-44. PubMed ID: 9137527
[TBL] [Abstract][Full Text] [Related]
29. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells.
Friesen C; Kiess Y; Debatin KM
Cell Death Differ; 2004 Jul; 11 Suppl 1():S73-85. PubMed ID: 15105835
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Wu XX; Ogawa O; Kakehi Y
Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
[TBL] [Abstract][Full Text] [Related]
31. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
[TBL] [Abstract][Full Text] [Related]
32. Effect of glutathione-modulating compounds on platinum compounds-induced cytotoxicity in human glioma cell lines.
Iida M; Doi H; Asamoto S; Sugiyama H; Sakagami H; Kuribayashi N; Takeda M; Okamura Y; Matsumoto K
Anticancer Res; 1999; 19(6B):5383-4. PubMed ID: 10697565
[TBL] [Abstract][Full Text] [Related]
33. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
[TBL] [Abstract][Full Text] [Related]
34. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
Tsukamoto N; Chen J; Yoshida A
Blood Cells Mol Dis; 1998 Jun; 24(2):231-8. PubMed ID: 9714700
[TBL] [Abstract][Full Text] [Related]
35. Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents.
Biroccio A; Benassi B; Fiorentino F; Zupi G
Neoplasia; 2004; 6(3):195-206. PubMed ID: 15153331
[TBL] [Abstract][Full Text] [Related]
36. Glutathione homeostasis in human hepatic cells: overexpression of gamma-glutamylcysteine synthetase gene in cell lines resistant to buthionine sulfoximine, an inhibitor of glutathione synthesis.
Tanaka T; Uchiumi T; Kohno K; Tomonari A; Nishio K; Saijo N; Kondo T; Kuwano M
Biochem Biophys Res Commun; 1998 May; 246(2):398-403. PubMed ID: 9610371
[TBL] [Abstract][Full Text] [Related]
37. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis.
Lopez SG; Luderer U
Free Radic Biol Med; 2004 Jun; 36(11):1366-77. PubMed ID: 15135172
[TBL] [Abstract][Full Text] [Related]
38. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
Goddard P; Valenti M; Kelland LR
Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451
[TBL] [Abstract][Full Text] [Related]
39. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Park WH
Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte growth factor protects RPE cells from apoptosis induced by glutathione depletion.
Jin M; Yaung J; Kannan R; He S; Ryan SJ; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4311-9. PubMed ID: 16249513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
